Evgenii Glukhaniuk: Addressing Delayed Diagnosis in Hereditary Hemorrhagic Telangiectasia
Evgenii Glukhaniuk, Hematologist at Gigeia-Med, shared a post on LinkedIn about a recent article by Hanny Al-Samkari et al, published in Blood, adding:
“I came across a new paper on hereditary hemorrhagic telangiectasia (HHT) from the CHORUS Registry.
HHT is not exceptionally rare, but it is still often diagnosed late. I once followed an outpatient with HHT who was also under the care of ENT and neurosurgery, so this paper felt especially relevant.”
Title: Clinical spectrum of hereditary hemorrhagic telangiectasia: data from the Comprehensive HHT Outcomes Registry of the US (CHORUS)
Authors: Hanny Al-Samkari, Cassi Friday, Raj S. Kasthuri, James R. Gossage, Charles G. Murphy, Peter Hountras, Karen L. Smith, Kristi Kirkland, Vivek Iyer, Vikas Prasad, Vaibhav Ahluwalia, Josanna Rodriguez-Lopez, Alison S. Witkin, Miles Conrad, Steven Hetts, Michael Ohliger, Murali Chakinala, Bryan A. Sisk, Melissa A. Beasley, Paul Kirkpatrick, Jonathan Lindquist, John T. Battaile, An Lu, Joseph Parambil, Keith McCrae, Vladimir Sheynzon, Kevin Whitehead, Cassidy Sion, Justin McWilliams, Lucas R. Cusumano, Scott O. Trerotola, Theodore G. Drivas, Mark Chesnutt, Claire Kaufman, Melissa Dickey, Danielle Boyce, Nolie Krock, Crystal Cottrill, Tania Competiello, Hara Levy, Marianne Clancy, Katharine Henderson, Jeffrey S. Pollak

Stay updated on all scientific advances with Hemostasis Today.
-
Sep 20, 2026, 05:17Maxime Dely: When ABO Compatibility Isn’t Enough for Safe Transfusion
-
Sep 20, 2026, 04:54William Aird: What Does a Complete History and Physical Really Mean?
-
Sep 20, 2026, 04:34Hons Saurabh Kaushik: Why Uncontrolled LDL Can Be Harmful
-
Sep 20, 2026, 03:58Salih Ehsan: The Complexities of HbF and HbA2
-
Sep 20, 2026, 03:22The Voices of People Living With Bleeding Disorders – EHC
-
Sep 20, 2026, 01:18Sebastian Mafeld: Has 2026 Changed How We Treat Pulmonary Embolism?
-
Sep 20, 2026, 01:16Pall T. Onundarson: DOACs – Monitoring, Tailoring Dose and Identifying Problems
-
Sep 20, 2026, 01:15Thierry Fumeaux: From Efficacy to Effectiveness – The Value of Real-World Evidence
-
Sep 20, 2026, 01:14Said El Shamieh: VEGFA Genetic Variants and Bleeding Risk During Warfarin Therapy